IN2014CN04922A - - Google Patents
Info
- Publication number
- IN2014CN04922A IN2014CN04922A IN4922CHN2014A IN2014CN04922A IN 2014CN04922 A IN2014CN04922 A IN 2014CN04922A IN 4922CHN2014 A IN4922CHN2014 A IN 4922CHN2014A IN 2014CN04922 A IN2014CN04922 A IN 2014CN04922A
- Authority
- IN
- India
- Prior art keywords
- formula
- paroxetine
- retains
- pharmaceutically acceptable
- alkyl group
- Prior art date
Links
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 abstract 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229960002296 paroxetine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261592896P | 2012-01-31 | 2012-01-31 | |
| PCT/JP2013/051858 WO2013115163A1 (ja) | 2012-01-31 | 2013-01-29 | パロキセチン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN04922A true IN2014CN04922A (enrdf_load_stackoverflow) | 2015-09-18 |
Family
ID=48870749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4922CHN2014 IN2014CN04922A (enrdf_load_stackoverflow) | 2012-01-31 | 2013-01-29 |
Country Status (16)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3344248T (lt) * | 2015-09-02 | 2022-06-27 | Trevena, Inc. | 6-narių azaheterociklinių junginių, kurių sudėtyje yra deltaopioidų receptorius moduliuojančių junginių, panaudojimo ir gamybos būdai |
| EP3582783B1 (en) | 2017-02-17 | 2023-06-07 | Trevena, Inc. | 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same |
| CN111533682B (zh) * | 2020-05-29 | 2022-03-01 | 清华大学 | 帕罗西汀及其类似物的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| TR200201156T2 (tr) * | 1997-06-10 | 2002-07-22 | Synthon B.V. | 4-Fenilpiperidin bileşimleri. |
| IT1308629B1 (it) * | 1999-02-23 | 2002-01-09 | Recordati Chem Pharm | Processo per la produzione di paroxetina. |
| KR101380190B1 (ko) | 2005-07-29 | 2014-04-11 | 콘서트 파마슈티컬즈, 인크. | 벤조 〔ｄ〕〔１,３〕―디옥솔 유도체 |
| US20070142389A1 (en) * | 2005-12-20 | 2007-06-21 | Pfizer Inc. | Piperidine derivatives |
| JP2009184924A (ja) | 2006-05-31 | 2009-08-20 | Eisai R & D Management Co Ltd | 生物学的試薬用化合物 |
-
2013
- 2013-01-29 TW TW102103327A patent/TW201334783A/zh unknown
- 2013-01-29 JP JP2013556400A patent/JP6055784B2/ja not_active Expired - Fee Related
- 2013-01-29 RU RU2014126321A patent/RU2616610C2/ru not_active IP Right Cessation
- 2013-01-29 AU AU2013216123A patent/AU2013216123B2/en not_active Ceased
- 2013-01-29 BR BR112014016197A patent/BR112014016197A8/pt active Search and Examination
- 2013-01-29 AR ARP130100262A patent/AR089837A1/es unknown
- 2013-01-29 WO PCT/JP2013/051858 patent/WO2013115163A1/ja active Application Filing
- 2013-01-29 MX MX2014007620A patent/MX355654B/es active IP Right Grant
- 2013-01-29 IN IN4922CHN2014 patent/IN2014CN04922A/en unknown
- 2013-01-29 US US13/752,638 patent/US8933100B2/en not_active Expired - Fee Related
- 2013-01-29 EP EP13744409.7A patent/EP2810942B1/en not_active Not-in-force
- 2013-01-29 CN CN201380005183.XA patent/CN104039777B/zh not_active Expired - Fee Related
- 2013-01-29 CA CA2861479A patent/CA2861479C/en not_active Expired - Fee Related
- 2013-01-29 KR KR1020147021114A patent/KR101950057B1/ko not_active Expired - Fee Related
- 2013-01-29 ES ES13744409.7T patent/ES2576082T3/es active Active
-
2014
- 2014-06-23 IL IL233327A patent/IL233327A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013115163A1 (ja) | 2013-08-08 |
| MX2014007620A (es) | 2014-09-15 |
| JPWO2013115163A1 (ja) | 2015-05-11 |
| CA2861479C (en) | 2017-10-10 |
| JP6055784B2 (ja) | 2016-12-27 |
| MX355654B (es) | 2018-04-26 |
| IL233327A0 (en) | 2014-08-31 |
| AR089837A1 (es) | 2014-09-17 |
| EP2810942B1 (en) | 2016-03-30 |
| EP2810942A1 (en) | 2014-12-10 |
| ES2576082T3 (es) | 2016-07-05 |
| US8933100B2 (en) | 2015-01-13 |
| CN104039777B (zh) | 2016-03-02 |
| CN104039777A (zh) | 2014-09-10 |
| KR101950057B1 (ko) | 2019-02-19 |
| RU2014126321A (ru) | 2016-03-20 |
| EP2810942A4 (en) | 2015-07-01 |
| IL233327A (en) | 2016-03-31 |
| CA2861479A1 (en) | 2013-08-08 |
| AU2013216123A1 (en) | 2014-07-17 |
| US20130197033A1 (en) | 2013-08-01 |
| AU2013216123B2 (en) | 2016-10-20 |
| BR112014016197A2 (pt) | 2017-06-13 |
| KR20140117454A (ko) | 2014-10-07 |
| RU2616610C2 (ru) | 2017-04-18 |
| BR112014016197A8 (pt) | 2017-07-04 |
| TW201334783A (zh) | 2013-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2875877C (en) | Syk inhibitors | |
| PH12017501326A1 (en) | Tgf-� inhibitors | |
| PH12017501429A1 (en) | Derivatives of betulin | |
| AU2012214029A8 (en) | Rorgammat inhibitors | |
| PH12016501822A1 (en) | Cyclopropaneamine compound | |
| AU2012313888A8 (en) | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH | |
| IN2014MN01897A (enrdf_load_stackoverflow) | ||
| MD20180040A2 (ro) | Inhibitori ai virusului hepatic C | |
| RS54526B1 (en) | USE OF PIRAZOLOSPIROKETONE DERIVATIVES AS ACETYL-COA CARBOXYLASE INHIBITORS | |
| GEP201606532B (en) | Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1 | |
| MX2014001595A (es) | Compuestos de imidazol, composiciones y metodos de uso. | |
| MY180083A (en) | Tetrahydropyrrolothiazine compounds | |
| TN2011000400A1 (en) | Inhibitors of beta-secretase | |
| PH12012501650B1 (en) | Heterocyclic compound | |
| IN2014DN07509A (enrdf_load_stackoverflow) | ||
| IN2012DN00765A (enrdf_load_stackoverflow) | ||
| IN2014CN04449A (enrdf_load_stackoverflow) | ||
| MY170262A (en) | Dicarboxylic acid compound | |
| MY185971A (en) | Pyranodipyridine compound | |
| PH12015502032A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| IN2014DN07996A (enrdf_load_stackoverflow) | ||
| PH12013501840A1 (en) | Nitrogen-containing saturated heterocyclic compound | |
| IN2014DN05972A (enrdf_load_stackoverflow) | ||
| MX359399B (es) | Inhibidores de 17alfa-hidroxilasa/c17-20-liasa. | |
| IN2014CN04922A (enrdf_load_stackoverflow) |